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Eukaryotic DNA is bound and interpreted by
numerous protein complexes in the context of chro-
matin. A description of the full set of proteins that
regulate specific loci is critical to understanding
regulation. Here, we describe a protocol called pro-
teomics of isolated chromatin segments (PICh) that
addresses this issue. PICh uses a specific nucleic
acid probe to isolate genomic DNA with its associ-
ated proteins in sufficient quantity and purity to allow
identification of the bound proteins. Purification of
human telomeric chromatin using PICh identified
the majority of known telomeric factors and uncov-
ered a large number of novel associations. We com-
pared proteins found at telomeres maintained by the
alternative lengthening of telomeres (ALT) pathway
to proteins bound at telomeres maintained by telo-
merase. We identified and validated several proteins,
including orphan nuclear receptors, that specifically
bind to ALT telomeres, establishing PICh as a useful
tool for characterizing chromatin composition.
INTRODUCTION
Despite substantial characterization efforts, chromosomes
remain poorly understood cellular organelles (Kornberg and
Lorch, 2007), in part due to an inability to purify given chromatin
segments in a manner that would allow the identification of
bound factors. During the past 25 years, various chromatin isola-
tion strategies have been pursued to establish locus-specific
protein composition (Boffa et al., 1995; Ghirlando and Felsen-
feld, 2008; Griesenbeck et al., 2003; Jasinskas and Hamkalo,
1999; Workman and Langmore, 1985; Zhang and Horz, 1982).
While each achieved enrichment of the targeted region, none
gave material of sufficient amount and purity to allow identifica-
tion of bound factors.
Other methods have been developed that connect specific
DNA sequences to the proteins that directly associate with
them. These include yeast one-hybrid (Li and Herskowitz,
1993) and nucleic acid affinity capture (Kadonaga and Tjian,
1986), which identify sequence-specific DNA-binding proteins.
These methods either use a ‘‘bait’’ DNA sequence outside ofits endogenous context, or an in vitro capture approach. While
these methods are useful, they do not provide a complete
description of what is found at the loci in vivo. Chromatin immu-
noprecipitation (ChIP) is a powerful technology to assess
whether a protein of interest is bound to a given genomic region.
ChIP relies on the use of antibodies and thus is limited to analysis
of the factors that are tested and does not establish a complete
description of composition.
To gain insight into locus-specific composition, we sought to
develop a strategy to purify an endogenous segment of chro-
matin in sufficient quantity and purity to identify the associated
proteins. Such a technology would permit a detailed correlation
between composition at a locus and phenotype, leading to
a deeper understanding of chromosome biology. We wanted
this method to be direct, relatively quantitative, and achievable
without the requirement for genetic engineering. Since the
DNA sequence provides a universal means of discriminating
a specific chromatin locus from others, we used nucleic acid
hybridization as the basis for purification.We demonstrate below
that we are able to isolate specific formaldehyde-crosslinked
chromatin regions and identify the proteins bound to those loci
using mass spectrometric analysis (MS). We call this method
proteomics of isolated chromatin segments (PICh) because it
uses the DNA to retrieve the protein information; this is opposite




To determine whether a protein of interest is localized to
a specific genomic region, a common approach is to combine
immunostaining and DNA in situ hybridization (immuno-FISH)
on fixed nuclei. We sought to develop a biochemical variation
of this method to affinity purify the proteins from a genomic chro-
matin locus using nucleic acid hybridization and use MS to iden-
tify the associated factors (PICh, see Figure 1). Initial attempts to
retrieve the target chromatin using conventional DNA capture/
FISH probes and common FISH reagents suffered from very
low yields and high levels of contamination from nonspecific
proteins (data not shown).
To maximize the specific enrichment of telomere-associated
proteins, optimization of the PICh procedure was necessary.
The resulting protocol is outlined in Figure 1. In brief, cells were
fixed, the chromatin was solubilized, a specific probe wasCell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc. 175
hybridized to the chromatin, the hybridized chromatin was
captured on magnetic beads, the hybrids were eluted, and the
associated proteins were identified. Extensive crosslinking with
formaldehyde was used to preserve protein-DNA and protein-
protein interactions. Unlike strategies based upon antibody-
antigen affinity, nucleic acid hybridization is insensitive to the
presence of ionic detergents (Rose et al., 2002), which allows
the use of these detergents throughout to limit contamination.
To increase the stability of the probe-chromatin interactions,
we used locked nucleic acid (LNA) containing oligonucleotides
as probes because LNA residues have an altered backbone
that favors base stacking thereby significantly increasing their
melting temperature (Vester and Wengel, 2004). To minimize
the steric hindrance (detrimental for yields) observed upon
immobilization of chromatin (Griesenbeck et al., 2003; Sandalt-
zopoulos et al., 1994), we used a very long spacer (Morocho
et al., 2005) between the immobilization tag and the LNA probe.
Finally we limited the coelution of nonspecific factors by using
desthiobiotin, a biotin analog with weaker affinity for avidin,
permitting a competitive gentle elution using biotin (Hirsch
et al., 2002).
Figure 1. Outline of the PICh Protocol176 Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc.Use of Telomeric Chromatin as a Proof-of-Principle
To establish this technology we chose to look at telomeres. Telo-
meres are an attractive target to test PICh because they are
abundant. There are approximately 100 telomeres per cell,
thus reducing the amount of starting material required to obtain
sufficient purified material for analysis. Moreover, since telo-
meres are of significant biological interest they have been well
characterized, allowing us to validate the technology. Telomeres
must be maintained to support continued cell division, a charac-
teristic feature of stem cells and cancer cells (Stewart and Wein-
berg, 2006). Maintenance is normally achieved by the activation
of telomerase, a reverse-transcriptase able to compensate for
sequence loss inherent to linear DNA replication. In a subset of
cancers (primarily those of mesenchymal origin) and in several
in vitro immortalized cell lines, telomeres are maintained in the
absence of telomerase by an alternative lengthening of telo-
meres pathway (ALT) that involves a poorly understood mecha-
nism based on recombination (Cesare and Reddel, 2008). ALT
telomeres exhibit heterogeneous length and can be found asso-
ciated with PML nuclear bodies (PML-NBs) for unknown reasons
(Molenaar et al., 2003).We used PICh to compare composition at
ALT telomeres with composition at telomerase-maintained telo-
meres. These data were used to validate PICh by asking whether
PICh could (1) identify the majority of previously characterized
associations with these telomeres and (2) identify novel proteins
whose association with telomeres could be verified using inde-
pendent means, including fluorescence microscopy.
PICh Reveals Telomere Composition
Weused PICh on three human cell lines with two distinct types of
telomere: two HeLa clones that are telomerase positive and
show different telomere length (S3 and 1.2.11) and the WI38-
VA13 ALT cell line (Figure 2A). We used a probe designed to
hybridize with telomere sequences and, as a control, a probe
with the same base composition but in a scrambled order
(referred to as ‘‘scrambled’’ below). Among the hits not present
in the scrambled purification, PICh identified 210 proteins asso-
ciated with HeLa 1.2.11 telomeres and 190 proteins associated
with ALT telomeres of the WI38-VA13 cells (see Tables S1 and
S2). Consistent MS results were obtained in replicate purifica-
tions (86.3%, i.e., 26 out of 190 proteins were found in only
one out of two ALT pulldowns, see Table S2). Ninety-eight
proteins (about half) were found at both types of telomeres.
These associations were specific to the telomere probe since
these proteins were not retrieved when PICh was performed
using the scrambled probe (see Table S3).
Most of the proteins previously shown to bind telomeres,
including low-abundance proteins such as Apollo (Lenain
et al., 2006; van Overbeek and de Lange, 2006), were found in
the telomere PICh (see Table 1). In total, 33 proteins previously
shown to associate with telomeres were found (Table 1). We
failed to identify four known or expected components of telo-
mere chromatin: the Tankyrase 1 poly-ADP ribose polymerase
(Smith et al., 1998); the Rad51D helicase (Tarsounas et al.,
2004); the Werner Syndrome helicase WRN (Crabbe et al.,
2004), although WRN interactors such as the WHIP ATPase
and the TERA protein were found; and the SIRT6 deacetylase
(Michishita et al., 2008). We also failed to identify the telomerase
reverse transcriptase TERT and Dyskerin at HeLa telomeres.
These proteins are unlikely to represent a constitutive compo-
nent of telomere chromatin based upon previous analyses so
would not be expected to be telomere bound in a significant
percentage of cells, especially in these nonsynchronized popula-
tions. In any case, lack of detection might reflect low abundance
at telomeres or might reflect inefficient crosslinking, although
formaldehyde was used by others to demonstrate the presence
of certain of these proteins at telomeres (Tankyrase 1, SIRT6,
Rad51D, and WRN). We conclude that PICh is robust since a
single experiment suffices to retrieve most of the known compo-
nents of the targeted locus (about 85%). To further validate the
technology, we asked whether other proteins present in these
preparations are bona fide telomere-associated proteins.
Validation of Telomere Associations
To determine the utility of PICh, novel associations must be
demonstrated to be bound to telomeres using independent
methods. We present several lines of evidence that suggest
that PICh is reliable.First, we assembled a rank-ordered list of factors identified
from the purified material based upon abundance, calculated
using the ratio of peptide number to protein size. Among the
top 25 scoring proteins from each of the two lists, 18 (HeLa)
and 17 (VA13) are known or expected telomere-interacting
proteins. We also detected maintenance type-specific associa-
tions (see Tables 1, S1, and S2 and references therein). For
instance, protein components of the telomerase holoenzyme
(GAR1, NHP2, and NAT10) were only found at HeLa telomeres.
Their absence at ALT telomeres is consistent with the absence
of hTR and hTERT expression in the VA13 cell line (Bryan
et al., 1997). Similarly, the PML protein, the 9-1-1 complex, the
MMS21 complex, the BLM helicase, or Topoisomerase III alpha,
proteins previously shown to be associated with ALT telomeres
(Nabetani et al., 2004; Potts and Yu, 2007; Stavropoulos et al.,
2002; Tsai et al., 2006), were only detected in the VA13 PICh
preparations, again confirming that maintenance-specific asso-
ciations can be identified. Finally, OBFC1 (Ob-fold containing
protein 1) is a putative human ortholog of yeast Stn1, a critical
telomere-binding protein in this organism. OBFC1 is found at
both types of telomeres by PICh, consistent with the anticipated
role for this protein at human telomeres (Martin et al., 2007).
We next validated the association of a set of proteins from the
list that had not previously been reported to interact with telo-
meres. As a stringent criterion for validity of the listed proteins,
we analyzed two of the five lowest ranked proteins from the
ALT list, the Fanconi Anemia Factor J (Fanc-J), a helicase ranking
in the last position, and the transcriptional corepressor RIP140.
We also analyzed the localization of NXP-2, a protein that ranked
in the middle of the ALT list. Consistent with our results from
PICh, all three proteins were found to associate with ALT telo-
meres by coimmunostaining (Figure 2B) but were not found to
associate withHeLa telomeres (data not shown). While we found
some cells harboring a pattern with RIP140 enriched at most
telomeres (Figure 2B), this pattern was uncommon. Because
this was seen in multiple cells, RIP140 is a valid association.
We then examined Homeobox containing protein 1
(HMBOX1), a putative transcription factor that had not been
previously reported as binding to telomeres (Chen et al., 2006)
but was identified by PICh in all cells tested (HeLa S3, 1.2.11,
and WI38-VA13; see Tables S1 and S2 and data not shown).
This protein is highly conserved in vertebrates but not in lower
eukaryotes. Interestingly the two closest related sequences in
C. elegans retrieved the F54A5.1 andCEH-37 proteins. The latter
is known to be telomeric in this organism, which harbors a similar
telomeric repeat sequence (TTAGGC) (Kim et al., 2003). Exoge-
nously expressed HMBOX1-Flag colocalized with the telomere
marker RAP1 in about 70% of WI38-VA13 nuclei (Figure 2C).
We could detect HMBOX1 at some telomeres in the HeLa
1.2.11 cell line but in only 10% of nuclei, with the majority of
staining being nontelomeric. Thus we cannot rigorously exclude
the possibility that it represents a false positive from the HeLa
PICh. However, its MS identification at both types of telomeres
and telomeric localization observed by immunostaining of
a majority of VA13 nuclei suggest that it is a true association in
both cell lines.
Therefore, of the eight novel telomere-associated proteins
identified by PICh that we tested (including four describedCell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc. 177
Figure 2. Purification of Telomeric Chromatin from Transformed Human Cell Lines
(A) Silver staining of material obtained from PICh purified telomere chromatin. Purifications from the two HeLa clones (S3 and 1.2.11) and theWI38-VA13 ALT cell
line are shown. T: PICh performed with the telomere-specific probe. S: PICh performed with the ‘‘scrambled’’ probe. Input represents 0.001% of the starting
material (3 3 104 cell equivalent), and purifications were from 5 3 108 cell equivalents/lane.
(B) Validation of selected PICh associations to ALT telomeres by immunostaining. Protein names are followed by their ranking order in the ALT list. NXP2 was an
HA-tagged construct transiently transfected (experiment performed 48 hr post-transfection). Endogenous RIP140 and Fanc-J are detected using specific anti-
bodies.
(C) Coimmunostaining with the Flag-tagged HMBOX1 and RAP1 in the WI38-VA13 and HeLa 1.2.11 cell lines (72 hr post-transfection).178 Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc.
below), seven showed clear association and one (HMBOX1)
showed ambiguous but likely telomere association. This indi-
cates that the false positive rate for telomere proteins identified
by PICh is likely to be low.
Orphan Receptors at ALT Telomeres
Shelterin proteins and histones are expected to be the most
abundant components at long telomeres because they play
a structural role at that locus. In addition to these proteins in
the ALT telomere preparations, we were surprised to identify
orphan receptors. The two most abundant of these receptors
were of the NR2 class: COUP-TF2 (#17) and TR4 (#18), which
both had 50% coverage by MS sequencing, thus ranking
higher than two shelterin proteins, POT1 and TPP1 (see Table
S2). Other NR2 proteins were also identified: COUP-TF1
(#118), EAR2 (#34), and TR2 (#99). These proteins belong to
the nuclear hormone receptor superfamily and are well charac-
terized transcription factors. It is unlikely that they originate
from contaminating promoter elements adjacent to telomeres
since these factors were not found at HeLa telomeres (short or
long). We were intrigued that these factors were highly enriched
at regions that have not been described as containing classical
promoters.
The specificity for these associations was confirmed by ChIP
using antibodies against COUP-TF2 and TR4 (Figure 3A) and
by immunoblot analysis on PICh-purified telomeres (Figure 3B).
Table 1. Incidence of Known Telomere Proteins Retrieved by
PICh
WI38-VA13 (ALT) HeLa 1.2.11 Both Not Found
PML Gar1 TRF1 SMC5 (ALT)
Rad9 NHP2 TRF2 SIRT6



















SP100 (ALT)Moreover these proteins were specifically enriched at telomeres
compared to other nuclear regions, as shown by immuno-FISH
and costaining experiments in the WI38-VA13 (ALT) cell line
(Figure 3D). COUP-TF1 was also found at ALT telomeres by cos-
taining but at a lower frequency, consistent with it having sig-
nificantly lower coverage in the MS (Figure 3D; Table S2). In
contrast, none of these proteins could be detected at HeLa
telomeres (see Table S1; Figures 3A and 3B). By immunoblot,
we found that, while COUP-TF2 and TR4 are expressed at higher
levels in the ALT cell line, COUP-TF1 is more abundant in HeLa
cells (Figure 3C) and yet is not found at telomeres. The specific
association of orphan receptors with ALT telomeres thus
does not appear to reflect differences in expression levels in
the cell lines tested but rather an association that is specific to
ALT telomeres.
To determine if these associations are unique to the particular
ALT cell line analyzed, we performed immuno-FISH experiments
in two other ALT cell lines,U2-OS andSa-OS-2. In contrast to the
WI38-VA13 cell line originating from SV40 immortalization
in vitro, U2-OS and Sa-OS-2 are human osteosarcoma tumor
cell lines. Both COUP-TF2 and TR4 were detected at telomeres
in U2-OS cells while only TR4 could be observed at Sa-OS-2
telomeres (see Figure S1). We suggest that orphan receptor
association with telomeres might be a common feature of ALT
cells since this was detected in three distinct ALT cell lines.
Since a growing number of orphan receptors, including TR2
(Park et al., 2007), are shown to be targeted to the PML-NB or
to discrete nuclear bodies (Chalkiadaki and Talianidis, 2005;
Chen et al., 2004; Wu et al., 2002), their presence at ALT telo-
meres could be due to the nonspecific crosslinking of orphan
receptors to telomeres localized at the PML-NB. We found,
however, that orphan receptors could be found associated
with telomeres in the absence of any PML signal (arrowheads
in Figure S1), arguing against this possibility.
Furthermore, we examined colocalization of orphan receptors
and telomeres using cells in metaphase. This experiment also
addresses the possibility that orphan receptors associate with
extrachromosomal telomere repeats (ECTR). ALT cells are char-
acterized by the presence of extrachromosomal telomere DNA
repeats (ECTR) of unknown function (Tokutake et al., 1998).
Despite the observation that the VA13 cells that we used have
negligible amounts of ECTR (Ford et al., 2001; Tokutake et al.,
1998), the recent proposal that ECTR localizes at PML bodies
(Fasching et al., 2007) raised the formal possibility that orphan
receptors are associated only with ECTR. If that were true,
they would not be expected to be colocalized with telomeres
at the ends of chromosomes. Immunostaining of metaphase
chromosomes revealed prominent signals for orphan receptors
colocalized with shelterin proteins at the tips of chromosomes
(Figure 4). We observed a similar pattern of chromosomal tip
localization for orphan receptors in the U2-OS cell line (not
shown). We conclude that orphan receptors associate with telo-
meric DNA located at the tips of chromosomes, leading us to
wonder what impact these nuclear receptors might have on
ALT telomere maintenance.(B and C) Quantification on the right is expressed as the fraction of nuclei showing the extent of telomere colocalization with the tested proteins in the analyzed
population.Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc. 179
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Figure 3. Analysis of COUP-TF2, COUP-TF1, and TR4 Association withWI38-VA13 ALT Telomeres
(A) CHIP with anti-COUP-TF2 and anti-TR4 antibodies. Immunoprecipitated DNA (from VA13 orHeLa 1.2.11) was probed on a slot-blot using a telomere-specific
probe (Telomere) or an Alu probe (Alu). Inputs represent 0.002% of starting material. Twenty percent of the IP was loaded. The right panel shows quantification
performed from two independent experiments (error bars represent SD from enrichment values). Immunoblots for COUP-TF2 and TR4 on PICh-purified telo-
meres (6% loaded) are shown.
(B) Western blot analysis for COUP-TF2 and TR4 levels in material purified from the indicated cell lines; TRF2 is a loading control for telomere material.180 Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc.
Orphan Nuclear Receptor Proteins May Underlie
Telomere PML-NB Colocalization
It has been proposed that a critical step in ALT maintenance
occurs in the PML-NB because disruption of PML expression
suppresses ALT (Jiang et al., 2007), and several proteins poten-
tially involved in telomere recombination are localized at PML-
NBs in ALT cells (Henson et al., 2002). We wondered if the
binding of orphan receptors to variant sequences known to be
at telomeres (see Discussion) might cause relocalization of telo-
meres to PML bodies and thus might impact telomere mainte-
nance. According to the PICh data there are at least five different
orphan receptors bound to telomeres. Knocking down the
expression of all five of these proteins at the same time is tech-
nically challenging, so we examined whether knocking down
the expression of the highest ranked associated protein
(COUP-TF2) would produce an effect on the localization of telo-
meres to PML-NBs.
Using shRNA, we derived stableWI38-VA13 cell lines in which
COUP-TF2 had been knocked down. In the absence of knock-
down, an average of 80%–90% of telomeres (as identified by
TRF2 immunostaining) are colocalized with the PML protein. In
the clones in which COUP-TF2 levels were reduced (Figure S2A),
telomeres were significantly delocalized from PML-NB (60%
colocalization, see Figure S2B). We conclude that COUP-TF2
expression levels are related to telomere-PML-NB association
frequency in theWI38-VA13 cell line.
To address whether delocalization of telomeres from PML-
NB impacts telomere maintenance, we measured telomere
length in the orphan receptor-depleted cell lines. A subtle
shortening of telomeres was observed in the two cell lines
that also showed knockdown of COUP-TF2, as indicated by
the smearing down of telomere restriction fragments from these
cell lines (Figure S2C). Despite this phenotype, we did not
notice an obvious proliferation defect. However, this analysis
is complicated by the observation that TR4 becomes upregu-
lated in many of these stable cell lines (Figure S2A) and by
the appearance of revertants in the cellular population (data
not shown). Our results are consistent with a possible redun-
dant function of orphan receptor action at telomeres. A full
phenotypic effect (total disruption of PML-NB association and
thus ALT maintenance) might require knocking down multiple
orphan receptors found at VA13 telomeres. Nonetheless, we
conclude that there is a subtle but measurable impact on telo-
meres caused by knocking down COUP-TF2, offering further
validation for a genuine association of this family of receptors
with ALT telomeres.
Insights into Telomeric Chromatin Structure
In addition to providing information regarding the identity of
proteins bound to a locus, PICh provides information on the rela-
tive levels of abundant proteins bound to a given sequence in
distinct cell types. For example, in the process of developing
PICh for use on telomeres, we noticed fewer histones in telo-
meric preparations fromHeLa S3 cells than in telomeric prepara-tions from HeLa 1.2.11 cells (Figure 2A). We pursued this finding
because of its possible relationship to the silencing of subtelo-
meric regions, known as telomere position effect (TPE), which
increases with the length of telomeres (Baur et al., 2001). TPE
is a classic example of gene silencing mediated by chromatin.
Indeed histone modifications and chromatin structure have
been suggested to play a major role in TPE in mammals (Blasco,
2007). In addition, we were interested in validating the efficacy of
PICh in measuring protein level.
The telomeres from HeLa 1.2.11 cells are longer than those in
S3 cells (20 kb on average versus <5 kb). Thus, the observation
that the shorter telomeres have less histones might reflect
a difference in nucleosome density or might simply reflect the
fact that there is less total telomeric material in S3 cells. When
we loaded the same amount of shelterin proteins, expected to
represent an equal loading of telomeric DNA (Loayza and De
Figure 4. Coimmunostaining of Orphan Receptors with Shelterin
Proteins on VA13 Metaphase Spreads
Top panels: COUP-TF2 and TRF2. Bottom panels: TR4 and RAP1.(C) Immunoblots showing COUP-TF2, COUP-TF1, and TR4 protein levels in HeLa 1.2.11 or VA13 cell lysates. b-tubulin is probed to control for loading.
(D) Immuno-FISH (COUP-TF2 and telomere probe) and coimmunostaining of RAP1 and TR4 or COUP-TF1 in VA13 nuclei. Frequency of colocalization is shown
on the right.Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc. 181
Lange, 2003), we observed greater nucleosome signal at the
longer telomeres (Figure 5A). ChIP with an anti-histone H3 anti-
body (Figure 5B) confirmed the lower nucleosomal density at
HeLa S3 telomeres (about 2.5-fold less nucleosomes/kb of telo-
meric DNA). Moreover, immunoblots performed on PICh purified
telomere material, normalized for shelterin abundance, also
confirmed the paucity of nucleosomes at the short HeLa S3 telo-
meres (Figure S3A).
This depletion of nucleosomes might explain the previously
observed smeary MNase digestion of short human telomeres,
while longer telomeres show amore discrete pattern (Tommerup
et al., 1994). These results suggest that, in the size range




Figure 5. Nucleosomal Density and Compo-
sition at Telomeres
(A) similar amounts of shelterins from HeLa 1.2.11
orS3were loaded to compare nucleosomal histone
to shelterin signals.
(B) CHIP with an anti-H3 antibody. The immunopre-
cipitated DNA (from HeLa S3 or 1.2.11) was probed
on a slot-blot using a telomere-specific probe
(Telomere) or an Alu probe (Alu); the panel on the
right shows quantitation from two independent
experiments. Inputs represent 0.002% of starting
material. Twenty percent of the IP was loaded.
Right panel shows quantifications normalized to
input telomere DNA and H3 IP at Alu repeats (error
bars represent SD from enrichment values).
(C) CHIP with anti-H1 and anti-H3 antibodies.
Immunoprecipitated DNA (from VA13 or HeLa
1.2.11) was probed on a slot-blot using a telo-
mere-specific probe (Telomere) or an Alu probe
(Alu); the panel on the right shows quantification
from two independent experiments (error bars
represent SD from enrichment values). Inputs
represent 0.002% of starting material. Twenty
percent of the IP was loaded. H1 versus H3 enrich-
ments at telomeres are normalized using the
signals obtained for these proteins with the Alu
repeats.
length, consistent with the greater TPE
observed with longer telomeres (Baur
et al., 2001). This is also consistent with
our failure to detect HP1 proteins at HeLa
S3 telomeres, while these factors were
readily identified in the other cell line
harboring longer telomeres. We hypothe-
size that a close relationship exists
between histone density, heterochromatin
protein associations, telomere length, and
TPE. Importantly, these data indicate that
nucleosomal chromatin is not refractory to
PICh.
In addition to canonical histones H3,
H2A, H2B, and H4, histone variants mac-
roH2A and testis-specific H2B were iden-
tified by PICh in the cell lines that contain
longer telomeres, HeLa 1.2.11 and WI38-
VA13. We confirmed the presence of macroH2A in these telo-
mere preparations by western blot on PICh material
(Figure S3B). We noticed an underrepresentation of the linker
H1 (Figure 2A, compare the input with the purified telomere
lanes), consistent with previous findings suggesting that mac-
roH2A and linker H1 may not coexist at specific loci (Abbott
et al., 2005).We confirmed the paucity of histone H1 at telomeres
using ChIP to compare the relative abundance of H1 to that of
H3 at telomeres or at Alu repeats (about 2.5- to 3-fold less,
Figure 5C). The underrepresentation of H1 in the telomeric nucle-
osomal arrays might explain the 40 bp shorter nucleosomal
repeat length previously observed at telomeres (Lejnine et al.,
1995). We conclude that for ubiquitous chromatin proteins182 Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc.
expected at most loci such as histones, PICh reflects relative
abundance of bound proteins and provides insights into chro-
matin structure.
DISCUSSION
PICh as a Tool for the Characterization of Chromatin
Composition
The identification of the proteins that interact with genomic
regions of interest is critical to the understanding of genome
biology. These questions have primarily been studied using
genetics, biochemical characterization of soluble complexes,
structural studies, chromatin immunoprecipitation, and cell
biology. These methods are powerful but do not provide infor-
mation concerning the complete composition of a locus. By es-
tablishing the ‘‘chromatin formula’’ of factors bound at specific
loci, PICh has the potential to advance the characterization of
chromosomes by providing a method to examine the entire set
of interacting proteins and how composition changes during
regulation. We used PICh to study telomeres and identified
most previously known factors and also new proteins that might
be relevant to telomere biology. These studies validate the
potential of PICh.
Amajor limitation for PICh is the need for a sufficient amount of
purified protein for identification by MS, which can require start-
ing with large amounts of material. Using conservative esti-
mates, a standard MS requires about a picomole of a given
protein. If the purification of a locus bound by a single protein
is considered and if that locus is unique, MS necessitates at least
half a picomole of diploid cells, amounting to several hundreds of
liters of a standard mammalian cell line. To circumvent issues
related to handling such large amounts of cells, we chose to
target human telomeres, which represent a relatively abundant
locus. Focusing on human telomeric chromatin decreases the
need for starting material by about 50-fold, as compared to
single copy loci of similar individual size, since each chromo-
some has two telomeres. In terms of relative abundance, telo-
mere sequences constitute 0.01% to 0.07% of the genome
in each cell. A technology that works on this type of target can
immediately be applied to other repeat sequences or low-copy
elements found in smaller genomes. For example, 0.01% corre-
sponds to a 1.2 and 12 kb locus in the yeast and fly genomes,
respectively, indicating that PICh as described here might be
suitable for the purification of single copy segments in those
organisms. Subsequent optimization might extend the use of
PICh to smaller segments or low repeat/single copy elements
in mammalian genomes.
PICh relies on nucleic acid hybridization to crosslinked chro-
matin and thus has the advantage that no genetic engineering
is required. There are, however, potential limitations. Avoiding
crosshybridization to other genomic regions is an issue that
requires a careful capture probe design. Moreover, our failure
to identify a few of the known telomere interactors suggests
that either these factors are not abundant at telomeres or these
factors fail to crosslink stably. We used formaldehyde, a 2 A˚
crosslinker, in this study; the use of other crosslinking
compounds might help resolve such issues by capturing loosely
bound, but biologically important, proteins.Complexity of Proteins Found at Telomeres
The relatively high number of proteins found at each class of telo-
meres (200) underscores the diversity of events occurring at
this locus. While it is possible that telomeres are continually
bound by a large number of proteins, this diversity might more
likely be caused by each individual telomere harboring distinct
composition at a given time. The cells used for these experi-
ments were not synchronized, and it is therefore expected that
PICh retrieved telomeres during various phases of the cell cycle:
for instance, the bi-modal distribution of Fanc-J in ALT cells de-
tected by immunflourescence (Figure 2B) might reflect this and
might explain its weak MS detection in our samples. The results
fromPICh as performed here, therefore, give an average compo-
sition of this locus. The use of synchronized cultures and PICh
might be informative in this regard.
It is inevitable that some proteins retrieved by PICh are bound
throughout the genome and thus do not play a specific role at
telomeres. For example, replication factors presumably fall into
this category, although their enrichment at telomeres might
also have a specific biological meaning (Gilson and Geli, 2007).
On the other hand, PICh has the ability to identify factors that
would be difficult to uncover using genetics because they either
play vital roles elsewhere or are redundant (as might be the case
for orphan receptors). It will be interesting to purify telomeres
frommore sources to correlate variations in the telomere formula
with phenotypic changes. The purification of telomeres from
other organisms will also be critical for a greater understanding
of telomere biology since fundamental protection or mainte-
nance mechanisms seem to be conserved.
Orphan Receptors at ALT Telomeres
Numerous proteins were seen that were specific to ALT telo-
meres, some of which were expected based upon previous liter-
ature (e.g., proteins involved in recombination) and some of
which were unexpected (e.g., orphan receptors). We focused
on the interaction between ALT telomeres and a subfamily of
orphan nuclear receptors as characterizing this unexpected
finding was important to validating the efficacy of PICh. The
presence of orphan receptors at ALT telomeres might be viewed
as a by-product of the ALT pathway (e.g., promoted by the
deprotection of telomeres) or as one of the causes for ALT. We
found that knocking down COUP-TF2, one of several orphan
receptors, had a measurable impact on association of ALT telo-
meres with PML bodies and on overall telomere length
(Figure S2). While this is consistent with a potential effector
role for orphan receptors in ALT maintenance, more work is
needed to test this hypothesis.
Why might orphan receptors bind to telomeres? The proximal
2 kb of human telomeres harbor variant sequences, inter-
spersed with the normal TTAGGG repeats or other telomere
variantmotifs (Baird et al., 1995).Oneof these variant sequences,
the ‘‘C-type’’ variant hexanucleotide repeat (TCAGGG), creates
a high-affinity binding site for orphan receptors (Figure 6). It is
possible that ALT telomeres are enriched in this motif. Alterna-
tively, these sites couldpre-exist in nonALTcells but beoccluded
by chromatin regulators (Benetti et al., 2007). The mechanisms
that promote orphan receptor binding and function at ALT telo-
meres require further investigation.Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc. 183
While PICh has been proven effective for the characterization
of the composition of telomeres, its applicability extends to other
loci. We have used PICh to purify mouse pericentric heterochro-
matin and have obtained a distinct ‘‘protein formula’’ (data not
shown). This approach can be used to characterize other nucle-
oprotein complexes, including nonchromatin targets. Although
technically challenging, we hope to extend PICh to single copy
elements. The ability to identify proteins bound to a given regu-
latory sequence based solely upon the identity of that DNA
sequence will allow the unbiased discovery of regulatory interac-
tions at key genomic loci.
EXPERIMENTAL PROCEDURES
Telomeric Chromatin Isolation by PICh
Chromatin Sample Preparation
From 20 l HeLa S3 cell equivalent (106 cells/ml): cells were crosslinked in
PBS–3% formaldehyde for 30 min at room temperature (RT) and washed
four times in PBS. Cells were then equilibrated in sucrose buffer and dounced
203with a tight pestle. Cells were equilibrated in glycerol buffer and pellet was
collected following centrifugation at 3200 g for 10 min at 4C. The pellet was
resuspended into the same volume of glycerol buffer. The pellet was frozen
into liquid nitrogen and stored at80C or used immediately for the next step.
The following volumes and numbers are given for one purification (that is
3 3 109 cell equivalent): the material was centrifuged at 2000 g for 2 min at
RT and the pellet was resuspended into the same pellet volume of 13
PBS—0.5%Triton X-100 and 90 ml of RNaseA (QIAGEN 100 mg/ml) were
added. The mixture was incubated for 60 min at RT with shaking then at 4C
for 12–16 hr and was washed six times in PBS. The material was equilibrated
in LBJD solution and the pellet was resuspended into 55% pellet volume of
LBJD solution. Samples were sonicated (Micro-tip, Misonix 3000) using the
following parameters: Power setting 7 (36–45 Watts), 15 s constant pulse,
and 45 s pause for a 7 min total process time. Sample was collected by centri-
fugation at 16000 g for 15 min at RT. Chromatin sample was then applied to
Sephacryl S-400-HR spin columns and incubated at 58C for 5 min.
LBJDLS pre-equilibrated streptavidin beads were added (Pierce Ultralink
streptavidin, 0.5 ml) and the sample was incubated for 2 hr at RT. Beads
were discarded and supernatant was saved.
Chromatin Capture
Samples were centrifuged 15 min at 16,000 g at RT and 1/100th final volume of
20% SDS was added together with the LNA probe (1 mM final concentration).
Hybridizationwas conducted as follows (25C for 3min, 70C for 6min, 38C
for 60 min, 60C for 2 min, 38C for 60 min, 60C for 2 min, 38C for 120 min,
Figure 6. Possible Scenario for Orphan Receptor
Binding to ALT Telomeres
R: purine (A orG), DR: direct repeat. A combination of telomere
variant repeat may constitute binding sites for orphan recep-
tors, which upon association to telomeres target the locus to
PML-NB.
25C final temperature). The sample was centrifuged at
16000 g for 15 min and the supernatant was diluted twice
with milliQ water and the LBJD pre-equilibrated MyONE C1
beads solution was added (typically 0.6–1 ml). The sample
was incubated for 12 hr at RT before increasing the volume to
10 ml with LBJD. Beads were washed seven times with 10 ml
with LBJD at RT and two times with 1 ml with LBJD at 42C.
Beads were resuspended into 1 ml of elution buffer.
The sample was incubated for 1 hr at RT with shaking and
temperature was raised to 65C for 10 min. The eluate was
precipitated using tri-chloroacetic acid (18% final) and the
pellet was resuspended into 50 ml of crosslinking reversal solution.
The sample was incubated at 99C for 25 min. The proteins were separated
using a 12% Bis-Tris acrylamide pre-cast gel (Invitrogen) or stored at 80C.
The proteins were revealed using the SilverQuest staining kit (Invitrogen) or
Colloidal Blue (Invitrogen) according to manufacturer’s instructions.
Colloidal blue-stainedgelswereused for subsequentMSanalysis. Laneswere
sliced in regions according to banding pattern and submitted to MS analysis.
Buffers Composition for PICh
PBS: 8 mM Na2HPO4; 2 mM KH2PO4; 137 mM NaCl; 2.7 mM KCl. Sucrose
buffer: 0.3 M Sucrose; 10 mM HEPES-NaOH, pH 7.9; 1% Triton X-100;
3 mM CaCl2; 2 mM MgOAc. Glycerol buffer: 25% glycerol; 10 mM HEPES-
NaOH, pH 7.9; 0.1 mM EDTA; 0.1 mM EGTA; 5 mM MgOAc. LBJD: 10 mM
HEPES-NaOH, pH 7.9; 100 mM NaCl; 2 mM EDTA, pH 8; 1 mM EGTA,
pH 8; 0.2% SDS; 0.1% Sarkosyl, protease inhibitors. LBJDLS: 10 mM
HEPES-NaOH, pH 7.9; 30 mM NaCl; 2 mM EDTA, pH 8; 1 mM EGTA, pH 8;
0.2% SDS; 0.1% Sarkosyl, protease inhibitors. Elution buffer: 12.5 mM Biotin
(Invitrogen cat#B20656), 7.5 mMHEPES-NaOH, pH 7.9; 75 mMNaCl, 1.5 mM
EDTA, pH 8; 0.75mMEGTA, pH 8; 0.15%SDS, 0.075%Sarkosyl. Crosslinking
reversal solution: 250 mM Tris, pH 8.8, 2% SDS, 0.5 M 2-mercaptoethanol.




where capitalized letters are LNA residues and small letters are DNA residues.
Synthesis was performed by Fidelity Systems.
Chromatin Immunoprecipitations
ChIP assays have been performed essentially as described (Lee et al., 2006).
Antibodies used for ChIP were anti-H3 (abcam 1791), anti-H1 (clone AE-4,
Santa Cruz), anti-TR4 (Perseus Proteomics), and anti-COUP-TF2 (abcam
ab50487). Immunoprecipitated DNA was spoted on a slot-blot apparatus
and probed with a telomere-specific probe or an Alu-specific probe. Error
bars represent standard deviation (SD) of enrichments values obtained from
independent experiments.
Cell lines, Culture Conditions, shRNA Treatment, and Plasmid
Constructs
HeLa S3 cells were grown in Joklik’s modifiedMEMwith 5%Calf Serum by the
National Cell Culture Center. HeLa 1.2.11, WI38-VA13, U2-OS, and Sa-OS2
were cultured in DMEM, 10% Calf Serum.
The HMBOX1 clone was obtained from the Invitrogen Human Ultimate ORF
collection and cloned in-frame with Flag in a pEGFP vector (Clontech) lacking
the GFP sequence. Flag sequence was introduced by PCR using the following184 Cell 136, 175–186, January 9, 2009 ª2009 Elsevier Inc.
primer pair: 50HMBOX1: AAGCTTCACCATGCTTAGTTCCTTTCCAGTGG and
30HMBOX1-FLAG: GCGGCCGCTCACTACTTGTCGTCATCGTCCTTGTAGTC
AGCAGCAGCGTCATCATCCAGGGCCTCTGTCTTGATTTC. ThePCRproduct
was ligated into a pGEM-T easy vector and sequenced. The gene was then
inserted into the pEGFP vector at HindIII-NotI sites.
shRNA constructs were obtained from Sigma (Mission shRNA collection). Of
the five sequences tested by transient transfection assays, only the following
was efficiently knocking down COUP-TF2 expression (COUP-TF2.1): CCGGG
CCGTATATGGCAATTCAATACTCGAGTATTGAATTGCCATATACGGCTTTTT.
Control shRNA is the scramble sequence available from Sigma.
Microscopy
Cells were grown in two chambers slides (Lab-TekII, Nunc). Cells were washed
in PBS and fixed in PBS containing 1% Triton X-100 and 3.7% formaldehyde
for 5 min. After two washes in PBS, cells were blocked in PBS-10% milk-3%
BSA containing 0.2% Tween and 0.2% NP-40 for 1 hr at RT. Incubation with
primary antibody was in blocking solution for 2 hr at RT or overnight at 4C.
Two 15min washes were performed after antibody incubation using PBS solu-
tions containing 0.2% Tween, 0.2% NP-40 and 300, then 400 mM NaCl.
Secondary antibodies (conjugated with Cy2, Cy3, or Cy5) were from Jackson
laboratories. Slides were counterstained with DAPI and mounted in Mowiol.
Antibodies used in this study are RAP1 1:40 (Abcam, ab4181), TRF2 1:40
(Santa Cruz H300 or Abcam ab13579), PML 1:100 (Santa Cruz, PGM3 or
H238), COUP-TF2 1:100 (Abcam ab50487), TR4 and COUP-TF1 1:100
(Perseus Proteomics), Flag 1:1000 (Sigma, M2), Fanc-J 1:100(Sigma), and
RIP140 1:100 (Abcam ab 42126). A standard FISH procedure was used when-
ever mentioned after post-fixation of the antibody staining, using the capture
probe at 1 mM in a standard hybridization buffer. An anti-biotin-FITC (Vector-
slab) was used to detect probe binding. Metaphase chromosome spreads
and staining were performed as described (Sullivan and Schwartz, 1995).
Stainings were analyzed using a Zeiss epifluorescence microscope and
a Hammamatsu CCD camera. Images were obtained using the Openlab soft-
ware, and the Photoshop CS software was used to color panels and prepare
the figures.
SUPPLEMENTAL DATA
Supplemental Data include three figures and three tables and can be found
with this article online at http://www.cell.com/supplemental/S0092-8674(08)
01520-1.
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